Date：23 July (Friday)
Time: 14:00 – 15:30 (GMT+8)
A graduate of Jichi Medical University, he began his research career at the Department of Cardiology, Stanford University, in 2001, where he was involved in research and development, animal testing, and clinical trials for a U.S. medical device venture. He has extensive advisory experience in the medical device field and is familiar with the medical situation in Japan and the United States. He has also participated in projects involving Japanese and U.S. regulatory authorities in medical devices and is working to establish a cross-border medical device ecosystem.
In addition to his research, he has been teaching at Stanford University since 2002 as a Stanford Biodesign Advisory Faculty member, where he is training entrepreneurs in the medical device field. He is also deeply involved in the establishment of the Japanese version of Biodesign. He is actively working to establish a Silicon Valley-style medical device ecosystem in Japan.
In 2012, just after large earthquake in Tohoku district, Japanese government had decided the strategic focus of the rebirth of the industry for future Japan, and the medtech was selected one of the areas. To create a ecosystem of medtech in Japan is the most important mission for that. To foster the medtech ecosystem, the entreprenourship education is the key component, so in 2015, Japan biodesign program had started. I will explain the past, now and future of Japanese medtech ecosystem focusing on the eduction.